发明名称 QUINOLONE COMPOUND
摘要 The present invention provides a compound represented by the formula (I) wherein X is a hydrogen atom or a fluorine atom; R is a hydrogen atom or alkyl; R1 is (1) cyclopropyl optionally substituted by to 3 halogen atoms or (2) phenyl optionally substituted by 1 to 3 halogen atoms; R2 is alkyl, alkoxy, haloalkoxy, a halogen atom, cyano, etc.; and R3 is 7-oxo-7,8-dihydro-1,8-naphthyridinyl, 3-pyridyl, etc., or a salt thereof. The compound of the present invention has excellent antimicrobial activity against Clostridium difficile and is useful for the prevention or treatment of intestinal infection such as Clostridium difficile-associated diarrhea.;
申请公布号 US2015005287(A2) 申请公布日期 2015.01.01
申请号 US201414193656 申请日期 2014.02.28
申请人 OTSUKA PHARMACEUTICAL CO., LTD. 发明人 ABUDUSAIMI Mamuti;YE Fangguo;SUN Jiangqin;MIYAMOTO Hisashi;CHENG Jay-Fei;OKA Daisuke
分类号 C07D215/56;C07D401/04;C07D417/04;C07D405/04;C07D401/14;C07D471/04;C07D498/06 主分类号 C07D215/56
代理机构 代理人
主权项 1. A compound represented by the formula (I)whereinX is a hydrogen atom or a fluorine atom;R is a hydrogen atom or alkyl;R1 is (1) cyclopropyl optionally substituted by 1 to 3 halogen atoms or (2) phenyl optionally substituted by 1 to 3 halogen atoms;R2 is a hydrogen atom; alkyl optionally substituted by 1 or 2 substituents selected from the group consisting of a halogen atom and hydroxyl; alkoxy; haloalkoxy; a halogen atom; cyano; cyclopropyl; nitro; amino; formyl; alkenyl or alkynyl; orR1 and R2 are bonded to form a 5- or 6-membered ring optionally substituted by alkyl;R3 is (1) a fused heterocyclic group of the formulawherein represents a single bond or a double bond,X1 is C(R5) or N,R4 is a hydrogen atom or alkyl, andR5 is (a) a hydrogen atom, (b) a halogen atom, (c) cyano, (d) nitro, (e) hydroxy, (f) alkyl optionally substituted by 1 to 3 halogen atoms, (g) alkenyl or alkynyl, (h) aryl, or (i) alkoxy optionally substituted by 1 to 3 halogen atoms,when X1 is C(R5), R4 and R5 are optionally bonded to form a 5or 6-membered ring optionally substituted by oxo,said fused heterocyclic group is optionally substituted by 1 or 2 substituents selected from the group consisting of a halogen atom, cyano, nitro, hydroxy and alkyl, (2) a group of the formulawhereinX2 is C(R8) or N, andR6, R7 and R8 are each independently, (a) a hydrogen atom, (b) a halogen atom, (c) cyano, (d) nitro, (e) amino, (f) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of a halogen atom, alkoxy and amino, (g) alkenyl, (h) alkynyl, (i) aryl, (j) formyl or CH═N—OH, (k) carboxy, (l) carbamoyl, (m) a 5- to 10-membered aromatic heterocyclic group optionally substituted by alkyl, or (n) alkenyloxy, (3) a group of the formulawhereinX3 and X4 are N, orX3 is N and X4 is CR″, wherein R″ is hydrogen atom, amino, hydroxy, alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of alkoxy and dimethylamino or mercapto, orX3 is CH and X4 is N,R′ is a hydrogen atom or alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of substituted hydroxyl and amino, andR6 is as defined above, (4) a group of the formulawherein represents a single bond or a double bond and R6 is as defined above, (5) 3-pyridyl optionally substituted by 1 or 2 substituents selected from the group consisting of (a) a halogen atom,(b) cyano,(c) nitro,(d) hydroxy,(e) amino,(f) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of a halogen atom, alkylamino, dialkylamino and hydroxy,(g) alkenyl, alkynyl(h) aryl,(i) cycloalkyl,(j) alkoxy,(k) alkylamino,(l) dialkylamino,(m) phenylamino optionally substituted by 1 to 3 halogen atoms,(n) a cyclic amino group optionally substituted by alkoxycarbonyl,(o) formyl,(p) carbamoyl optionally substituted by alkyl optionally substituted by hydroxy, and(q) a 5- to 10-membered aromatic heterocyclic group optionally substituted by alkyl, (6) 4-pyridyl optionally substituted by a halogen atom, (7) 5-pyrimidinyl optionally substituted by 1 or 2 substituents selected from the group consisting of amino, alkylamino, dialkylamino and carboxy, (8) 2-indolyl, 3-indolyl, 5-indolyl, 6-indolyl, benzofuranyl, benzothiophenyl, benzoxazolyl or benzothiazolyl, each optionally substituted by 1 or 2 substituents selected from the group consisting of (a) a halogen atom,(b) cyano,(c) nitro,(d) hydroxy,(e) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of amino, alkoxycarbonylamino, alkylamino and dialkylamino,(f) alkoxy,(g) formyl,(h) carboxy, and(j) amino optionally substituted by 1 or 2 substituents selected from the group consisting of (i) alkoxycarbonyl,(ii) alkylcarbonyl optionally substituted by a substituent selected from the group consisting of (A) cycloalkyloxy optionally substituted by 1 to 3 alkyl,(B) alkylamino,(C) dialkylamino,(D) a cyclic amino group optionally substituted by alkoxycarbonyl, and(E) a halogen atom,(iii) phenylcarbonyl optionally substituted by 1 to 3 substituents selected from the group consisting of alkyl and alkoxy,(iv) cycloalkylcarbonyl,(v) a 5- to 10-membered aromatic heterocyclylcarbonyl group optionally substituted by alkyl optionally substituted by 1 to 3 halogen atoms,(vi) benzylcarbonyl optionally substituted by 1 to 3 substituents selected from the group consisting of a halogen atom and alkoxy,(vii) arylsulfonyl optionally substituted by alkoxy,(viii) cycloalkylalkylsulfonyl optionally substituted by 1 to 3 substituents selected from the group consisting of alkyl and oxo,(ix) a 5- to 10-membered aromatic heterocyclylsulfonyl group optionally substituted by 1 to 3 alkyl, and(x) —C(═N—CN)—SR9 wherein R9 is alkyl, (9) a group of the formulawhereinone of Y1, Y2, Y3 and Y4 is N or N+ (—O−), and the remaining three are each C(R25), C(R26) and C(R27),W is O, S, NH or N(R23)R23 is a hydrogen atom or alkyl, andR24, R25, R26 and R27 are each independently, (a) a hydrogen atom, (b) cyano, or (c) nitro, (10) a group of the formulawhereinR28 is a hydrogen atom or hydroxy, andR29 is a hydrogen atom or alkyl, (11) a group of the formulawhereinX5 is C(R11) or N,X6 is CH2, C(═O), O, S, SO2 or N(R12),X7 is CH(R13), C(═O) or N(R14),X8 is CH(R15) or C(═O),R10, R12 and R14 are each independently, (a) a hydrogen atom or (b) alkyl, andR11, R13 and R15 are each independently, (a) a hydrogen atom, (b) a halogen atom, (c) cyano, (d) nitro, (e) amino, (f) alkylamino, (g) dialkylamino, (h) alkyl optionally substituted by hydroxy, or (i) alkenyl,when X5 is C(R11), R10 and R11 are optionally bonded to form a 5- or 6-membered ring optionally substituted by alkyl or oxo, andwhen X6 is N(R12) and X7 is CH(R13), R12 and R13 are optionally bonded to form a 5- or 6-membered ring, (12) a group of the formulawherein R16 is (a) a hydrogen atom, (b) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of cyano, alkylamino and dialkylamino, (c) alkenyl optionally substituted by carboxy, (d) formyl, (e) carboxy, (f) carbamoyl, (g) —C(R17)═N—OH wherein R17 is a hydrogen atom, cyano or hydroxy, (h) a 5- to 10-membered aromatic heterocyclic group optionally substituted by alkyl, alkoxycarbonyl, carboxy or phenyl, or (i) cyano, (13) a group of the formulawhereinR18 is a hydrogen atom or alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of a halogen atom and phenyl,n is 0 or 1,R19, R20 and R33 are each independently, (a) a hydrogen atom, (b) a halogen atom, (c) cyano, (d) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of (i) a halogen atom,(ii) cyano,(iii) hydroxy,(iv) amino,(v) alkylamino,(vi) dialkylamino, and(vii) a cyclic amino group optionally substituted by alkyl, (e) alkoxy, (f) amino optionally substituted by 1 or 2 substituents selected from the group consisting of (i) alkylcarbonyl optionally substituted by a cyclic amino group,(ii) alkylsulfonyl,(iii) carbamoyl,(iv) alkyl, cycloalkyl or cycloalkylalkyl, and(v) 5- to 10-membered saturated heterocyclic group, (g) carboxy, (h) alkoxycarbonyl, (i) carbamoyl optionally substituted by alkyl optionally substituted by amino, alkylamino, dialkylamino or alkoxycarbonylamino, (j) formyl, (k) a 5- to 10-membered aromatic heterocyclic group optionally substituted by alkyl, (l) —CH═N—OR21 wherein R21 is a hydrogen atom or alkyl optionally substituted by alkylamino or dialkylamino, (m) nitro, (n) a 5- to 10-membered saturated heterocyclic group optionally substituted by amino, (o) phenyl, or (p) —NHC(SMe)=CHCN, (14) a group of the formulawhereinR30 is (a) a hydrogen atom, (b) a halogen atom, (c) cyano, (d) alkyl optionally substituted by 1 to 3 substituents selected from the group consisting of a halogen atom and hydroxy, (e) alkenyl, (f) alkynyl, (g) alkoxy, (h) formyl, (i) —CH═N—OH, or (j) carbamoyl, (15) naphthyl or isochromenyl, (16) quinolyl or isoquinolyl, or their oxide derivatives, (17) a group of the formula (18) a group of the formulawhereinU is O or S, andR31 is (a) a hydrogen atom, (b) a halogen atom, (c) alkyl optionally substituted by 1 to 3 halogen atoms, (d) carboxy, (e) nitro, (f) cyano, or (g) amino, (19) a group of the formulawhereinR32 is (a) a halogen atom, (b) phenyl, or (c) a group of the formula (20) a group of the formulawhereinR34 and R35 are each independently, (a) a hydrogen atom, or (b) aminoalkyl,orR34 and R35 are bonded to form a 6-membered ring optionally substituted by amino or oxo, (21) a group of the formulawherein R36 is (a) a hydrogen atom, (b) a halogen atom, (c) nitro, or (d) thienyl, or (22) a group of the formulaor a salt thereof.
地址 Tokyo JP